CNSP · CNS Pharmaceuticals, Inc. · Executive Compensation
Market Cap
$8.68M
Shares
1.46M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| John Climaco | Former Chief Executive Officer | $1,168,591 |
| Christopher Downs | Senior Vice President – Finance, (Former Chief Financial Officer) | $728,809 |
| Sandra L. Silberman | Former Chief Medical Officer | $720,818 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| John M. Climaco | CEO | $1,103,680 |
| John Climaco | Former Chief Executive Officer | $1,103,680 |
| Christopher Downs | Senior Vice President – Finance, (Former Chief Financial Officer) | $621,050 |
| Christopher S. Downs | CFO | $621,050 |
| Sandra L. Silberman | Former Chief Medical Officer | $361,641 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| John M. Climaco | CEO | $624,348 |
| John Climaco | Chief Executive Officer | $624,348 |
| Christopher Downs | Chief Financial Officer | $401,515 |
| Christopher S. Downs | CFO | $401,515 |
| Sandra L. Silberman | Chief Medical Officer | $270,152 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| John M. Climaco | CEO | $827,928 |
| John Climaco | Chief Executive Officer | $827,928 |
| Christopher Downs | Chief Financial Officer | $481,224 |
| Christopher S. Downs | CFO | $481,224 |
| Sandra L. Silberman | Chief Medical Officer | $281,306 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| John Climaco | Chief Executive Officer | $845,940 |
| John M. Climaco | CEO | $845,940 |
| Christopher Downs | Chief Financial Officer | $480,475 |
| Christopher S. Downs | CFO | $480,475 |
| Sandra L. Silberman | Chief Medical Officer | $269,238 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| John M. Climaco | CEO | $1,572,908 |
| John Climaco | Chairman and Chief Executive Officer | $1,572,908 |
| Christopher Downs | Chief Financial Officer | $790,999 |
| Christopher S. Downs | CFO | $790,999 |
| Sandra L. Silberman | Chief Medical Officer | $340,958 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| John Climaco | Chairman and Chief Executive Officer | $1,229,304 |
| John M. Climaco | CEO | $1,229,304 |
| Christopher Downs | Chief Financial Officer | $1,154,115 |
| Christopher S. Downs | CFO | $1,154,115 |
| Sandra L. Silberman | Chief Medical Officer | $272,721 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| John M. Climaco | CEO | $164,300 |
| John Climaco | Chairman and Chief Executive Officer | $164,300 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michal Fisher | independent member of the Company's Board | Appointed | 2026-05-04 |
| Jerzy (George) Gumulka | member of the Company's Board of Directors | Resigned | 2026-05-04 |
| Lynne Kelley | Chief Medical Officer | Appointed | 2026-03-02 |
| Christopher Downs | Chief Financial Officer | Resigned | 2026-02-17 |
| Christopher Downs | Senior Vice President – Finance | Appointed | 2026-02-17 |
| Steve O'Loughlin | Chief Financial Officer | Appointed | 2026-02-17 |
| John Climaco | member of the Company's Board of Directors | Resigned | 2025-12-17 |
| John Climaco | chief executive officer | Resigned | 2025-12-17 |
| Rami Levin | member of the Company's Board of Directors | Appointed | 2025-12-17 |
| Rami Levin | Chief Executive Officer and President | Appointed | 2025-12-17 |
| Amy Mahery | Director | Appointed | 2025-11-21 |
| Bettina Cockroft | Director | Appointed | 2025-11-21 |
| Faith Charles | Director | Appointed | 2025-11-21 |
| Jeffry R. Keyes | Director | Appointed | 2025-11-21 |
| Jerzy (George) Gumulka | Director | Appointed | 2025-11-21 |
| John Climaco | Director | Appointed | 2025-11-21 |
Key facts
CIK
1729427
CUSIP
18978H508
13F (30d)
10 filings
10 filers
Visit website
Investor relations